Joseph Kannam is a Cardiology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 15 publications with 261 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Brookline Ave
Beth Israel Hospital
Boston, MA 022155400
Telephone
617-667-3960Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202532 payments$13,925openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202440 payments$19,363openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year202333 payments$26,750openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83%Beta blocker18.4%Metoprolol Succinate69%Carvedilol18%Metoprolol Tartrate7%Atenolol5%Sotalol1%Part D<11 patientsStatin17.9%Atorvastatin Calcium54%Rosuvastatin Calcium40%Simvastatin4%Pravastatin Sodium2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
13.2%Factor Xa inhibitor10.3%Eliquis80%Xarelto20%Part D≥142 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D≥37 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.3%SGLT2 inhibitor2%Farxiga71%Jardiance29%Part D≥24 patientsPotassium supplement1.1%Potassium Chloride100%Part D≥20 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A RARE CAUSE OF HYPERTENSION: MID-AORTIC SYNDROME DIAGNOSED IN ADULTHOOD
Journal of the American College of Cardiology
2024 - Incidence of Myopericarditis and Myocardial Injury in Coronavirus Disease 2019 Vaccinated Subjects
The American Journal of Cardiology
2021 - The Impact of the COVID-19 Pandemic on Cardiovascular Fellows-in-Training
Journal of the American College of Cardiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”